These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2159273)
21. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity. Schneider MR J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317 [TBL] [Abstract][Full Text] [Related]
22. Aqua[1,1-bis(4-hydroxyphenyl)-1,2-diamino-2-phenylethane]- sulfatoplatinum(II), a new compound for the treatment of the mammary carcinoma. Gust R Arch Pharm (Weinheim); 1994 Jan; 327(1):49-54. PubMed ID: 8117188 [TBL] [Abstract][Full Text] [Related]
23. [Potential antineoplastics, 6. Synthesis of hexestrol derivatives with alkylating side chains]. Hamacher H; Mangold C Arch Pharm (Weinheim); 1983; 316(3):271-81. PubMed ID: 6305306 [No Abstract] [Full Text] [Related]
24. N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity. von Angerer E; Egginger G; Kranzfelder G; Bernhauer H; Schönenberger H J Med Chem; 1982 Jul; 25(7):832-7. PubMed ID: 6809943 [TBL] [Abstract][Full Text] [Related]
25. 2-Phenylindenes: development of a new mammary tumor inhibiting antiestrogen by combination of estrogenic side effect lowering structural elements. Schneider MR; Ball H J Med Chem; 1986 Jan; 29(1):75-9. PubMed ID: 3941415 [TBL] [Abstract][Full Text] [Related]
26. [Mammary-tumor-inhibiting antiestrogens of the 3,3'-dihydroxy-alpha, beta-dialkylstilbene type (author's transl)]. Schneider M; von Angerer E; Kranzfelder G; Schönenberger H Arch Pharm (Weinheim); 1980; 313(11):919-25. PubMed ID: 7447652 [No Abstract] [Full Text] [Related]
27. Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens. Hartmann RW Cancer Treat Rev; 1984 Mar; 11 Suppl A():155-61. PubMed ID: 6329512 [No Abstract] [Full Text] [Related]
28. Hexestrol-linked cytotoxic agents: synthesis and binding affinity for estrogen receptors. Köhle H; Krohn K; Leclercq G J Med Chem; 1989 Jul; 32(7):1538-47. PubMed ID: 2544725 [TBL] [Abstract][Full Text] [Related]
29. Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties. Schneider MR; Ball H; Schönenberger H J Med Chem; 1985 Dec; 28(12):1880-5. PubMed ID: 4068009 [TBL] [Abstract][Full Text] [Related]
30. Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complex. Spruss T; Gust R; Müller R; Engel J; Schönenberger H Arch Pharm (Weinheim); 1990 Feb; 323(2):99-102. PubMed ID: 2334275 [TBL] [Abstract][Full Text] [Related]
31. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity. von Angerer E; Strohmeier J J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590 [TBL] [Abstract][Full Text] [Related]